Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 280 participants.
Also called NCT02649946
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 280 participants
- Sponsor
- Registry
-
NCT02649946
-
- Other papers using this trial's data
- Prospective, randomized, multicenter clinical study comparing a self-expanding covered stent to percutaneous transluminal angioplasty for treatment of upper extremity hemodialysis arteriovenous fistula stenosis
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Austria, Belgium, Germany, Netherlands, New Zealand, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT02649946. Randomized; no masking; primary purpose treatment. Start 2016-06 (actual); primary completion 2018-08 (actual). Results posted on 2019-05-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Clinical Study of the BARD® COVERA™ Arteriovenous (AV) Stent Graft
- Acronym
- AVeNEW
- Condition
- Stenosis
- Condition
- Restenosis
- Intervention (Device)
- Covera Vascular Covered Stent following PTA
- Intervention (Procedure)
- Percutaneous Transluminal Angioplasty (PTA) with Uncoated PTA Balloon
- Lead sponsor
- C. R. Bard
Record details
- Record id
cardio:ct-nct02649946- Content hash
e6c29d9e95b4cc6007a28d1cdab1132bc56e86e3e130733c34ced041ace1b23a